Suppr超能文献

血管性血友病分类的分子学方法

A molecular approach to the classification of von Willebrand disease.

作者信息

Schneppenheim R, Budde U, Ruggeri Z M

机构信息

Department of Paediatric Haematology and Oncology, University Hospital Hamburg, Martinistrasse 52, D-20246 Hamburg, Germany.

出版信息

Best Pract Res Clin Haematol. 2001 Jun;14(2):281-98. doi: 10.1053/beha.2001.0134.

Abstract

The marked heterogeneity of von Willebrand disease was already recognized by von Willebrand in 1926. The accumulating knowledge of the different clinical phenotypes and the pathophysiological basis of the disease was translated into a classification that differentiated between quantitative and qualitative defects by means of quantitative and functional parameters and by analysing the electrophoretic pattern of von Willebrand factor multimers. The increasing number of different von Willebrand disease phenotypes required a revision of the nomenclature at a time when only a few types of von Willebrand disease had already been analysed at the molecular level. Consequently, the molecular data played only a minor role in the revised classification. Given the pronounced, even intra-individual, variation in the manifestation of von Willebrand disease and the diagnostic difficulties caused by a non-standardized methodology, it is clear that biochemical methods alone are insufficient for a clear classification. The advent of molecular techniques provided the opportunity for genotype-phenotype studies that recently helped to elucidate or confirm not only the important functions of von Willebrand factor and the steps of its post-translational processing, but also many disease-causing defects. The reproducible correlation between certain phenotypes and particular mutations can now be used for a molecular approach towards a final classification of von Willebrand disease, equally useful for the clinician and for research requirements.

摘要

1926年,冯·维勒布兰德就已认识到血管性血友病具有显著的异质性。随着对该疾病不同临床表型和病理生理基础的认识不断积累,人们将其转化为一种分类方法,通过定量和功能参数以及分析血管性血友病因子多聚体的电泳图谱来区分定量缺陷和定性缺陷。在仅对少数几种血管性血友病类型进行分子水平分析时,不同血管性血友病表型数量的不断增加要求对命名法进行修订。因此,分子数据在修订后的分类中仅起次要作用。鉴于血管性血友病表现存在明显差异,甚至在个体内部也有差异,且非标准化方法会导致诊断困难,显然仅靠生化方法不足以进行明确分类。分子技术的出现为基因型 - 表型研究提供了机会,最近这不仅有助于阐明或确认血管性血友病因子的重要功能及其翻译后加工步骤,还能发现许多致病缺陷。现在,某些表型与特定突变之间可重复的相关性可用于分子方法对血管性血友病进行最终分类,这对临床医生和研究需求同样有用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验